Literature DB >> 14642403

Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study.

Riikka Rontu1, Pekka J Karhunen, Erkki Ilveskoski, Jussi Mikkelsson, Olli Kajander, Markus Perola, Antti Penttilä, Anna-Maija Koivisto, Terho Lehtimäki.   

Abstract

High-density lipoprotein-associated paraoxonase 1 (PON1) enzyme can retard the oxidation of lipids. The methionine for leucine substitution at position 55 (M/L55) of the PON1 protein is associated with lower (MM genotype) or higher (ML or LL genotype) expression of the gene affecting serum level of PON1. We studied the association of the PON1 M/L55 genotype with the extent of atherosclerosis in an autopsy series of Finnish males. Areas of the coronary arteries and the aorta covered with fatty streaks and fibrotic and complicated lesions were measured from a total of 700 cases. Carriers of the MM genotype (14.4% of subjects) had larger percentual areas of fatty streaks in their left anterior descending coronary artery (P=0.014) and right coronary artery (P=0.004), as well as in thoracic (P<0.001) and abdominal aorta (P=0.010) compared to carriers of the LL or ML genotype. A PON1 genotype-by-smoking interaction was observed on the area of fatty streaks in left anterior descending coronary artery (P=0.011) and right coronary artery (P=0.005); the association between fatty streaks and MM genotype was evident only among non-smokers, whereas in smokers this association was abolished. The areas of more advanced atherosclerotic lesions did not vary significantly between the genotype groups. These data suggest that the genetic variation of PON1 affects the formation of early atherosclerotic lesions and that the effect is modified by smoking.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642403     DOI: 10.1016/j.atherosclerosis.2003.07.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  2 in total

1.  Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.

Authors:  H Karsen; I Binici; M Sunnetcioglu; A I Baran; M R Ceylan; S Selek; H Celik
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

2.  Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study.

Authors:  Sebastian Okser; Terho Lehtimäki; Laura L Elo; Nina Mononen; Nina Peltonen; Mika Kähönen; Markus Juonala; Yue-Mei Fan; Jussi A Hernesniemi; Tomi Laitinen; Leo-Pekka Lyytikäinen; Riikka Rontu; Carita Eklund; Nina Hutri-Kähönen; Leena Taittonen; Mikko Hurme; Jorma S A Viikari; Olli T Raitakari; Tero Aittokallio
Journal:  PLoS Genet       Date:  2010-09-30       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.